RxSight, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
140.03 |
136.47 |
151.12 |
176.42 |
162.35 |
| Przychód Δ r/r |
0.00% |
-2.54% |
10.74% |
16.74% |
-7.97% |
| Przychód (min) |
139.97 |
135.86 |
122.70 |
176.42 |
151.73 |
| Przychód (max) |
140.10 |
137.16 |
203.81 |
176.42 |
182.03 |
| EBITDA (średnia) |
-45.66 |
-44.50 |
-49.28 |
-57.53 |
-52.94 |
| EBIT (średnia) |
-47.72 |
-46.51 |
-51.50 |
-60.12 |
-55.33 |
| EBIT % |
-34.08% |
-34.08% |
-34.08% |
-34.08% |
-34.08% |
| Zysk netto (średni) |
-26.55 |
-41.49 |
-42.34 |
-33.56 |
-29.73 |
| Zysk netto % |
-18.96% |
-30.40% |
-28.01% |
-19.02% |
-18.31% |
| EPS (średnia) |
-0.72 |
-1.07 |
-1.01 |
-0.79 |
-0.77 |
| Liczba analityków (Przychody) |
7 |
6 |
11 |
9 |
3 |
| Liczba analityków (EPS) |
5 |
4 |
8 |
8 |
7 |
| symbol |
RXST |
RXST |
RXST |
RXST |
RXST |